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The treatment of experimental cattle with phenylbutazone was a long postponed
sequel to the field observations on its efficacy in ephemeral fever. Except for the
experiments with Finadyne, which were carried out while Dr Uren was at the
National University, the clinical observations were share(j. Ms Zakrzewski did all
the experimental development of the tests for interferon ,and its application. The
observations were carried out on a 2 hourly cycle for several days by an integrated
" team of veterinarians and technicians. The supporting group of technicians processed
the samples in the laboratory in real time. Dr St.George wrote the paper.
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THE PATHOGENESIS AND TREATMENT OF BOVINE EPHEMERAL FEVER
T D St.George, M F Uren and H Zakrzewski
CSIRO, Division of Tropical Animal Science, Long Pocket Laboratories. Private Bag
No.3 PO, Indooroopilly, QLD 4068, AUSTRALIA.
The clinical signs occur in stages. To the clini-
cal signs shown in Figure I, should be added
bouts of accelerated heart rate and rapid respir-
ation, which do not necessarily happen only in
the febrile periods. The complications that may
occur are shown in Table I.
Bovine ephemeral fever is regarded by many
veterinarians as an easy disease to diagnose. The
short course of the fever, 2-3 days, and rapid
recovery from severe illness are key elements
which make laboratory confirmation unnecess-
ary in an epidemic situation where cases are
available in various stages of the disease. How-
ever, many single cases, in a non-epidemic
framework, appear to be just sick cows, with
nothing remarkable about them. Differential
diagnosis can be difficult without reliable path-
ognomonic signs. The considerable variation in
the nature and severity of clinical signs has been
taken as evidence that the virus targets a range of
tissues, even brain or nerves. Our efforts over the
last 3 years have been directed to the develop-
ment of a unifying hypothesis, namely, that
ephemeral fever is fundamentally a toxaemia of
varying severity, with consequential effects on
tissue and biochemistry producing the sympto-
matology.
TABLE 1
BEF Complications
Outcome Effect likel.v
-death
-death
-recovery 3-6 months
-loss of I lactation &
calf
Pneumonia or severe
emphysema
Air under skin
Temporary fertility loss
in bulls
Late abortion cows
Full or partial agalactia
for I lactation
Secondary mastitis
-next lactation normal
-recovery with
antibiotic treatment
-full recovery
-slow & incomplete
recovery
-death
Paralysis for I or 2 days
Paralysis prolonged
Paralysis', loss or reflexes,
coma
The general pattern of ephemeral fever has
been well described, (Anon 1937; Mulhearn
1937; Mackerras et a11940; van der Westhuizen
et a11967; Inaba 1973), but a much more precise
knowledge of the sequence and interrelationship
of clinical events was necessary to explain the
severity of many cases, particularly those with
apparent but temporary neural signs.
Our first step was to observe experimental dis-
ease, hour by hour, over several days, after an
incubation period of approximately 3 days. This
close observation revealed that the fever was
phasic, with the phases compressed or spaced in
various individuals, (Fig. 2). Heart and respirat-
ory rates usually increased during fever, but
increase was not always related to fever. In most
cases, recovery occurred as fever declined. Clini-
cal signs were generally mild in the first phase
and much more severe in the later febrile phase.
or phases. These observations confirmed what
had been suspected from twice daily obser-
vations of sentinel cattle in natural outbreaks
(Anon 1937; St. George et al 1984).
The exception to the mild signs in the first
clinical phase of natural cases in lactating cows
was a severe drop in milk yield which occurs in
natural disease (Davis et al 1984). Our first
efforts to isolate BEF virus from blood samples.
collected hourly, were unsuccessful as the
Figure I. A schematic representation of the course of
ephemeral fever in acow. Each stage may be more pro-
longed. There is a great variation in the severity of
clinical signs.
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In experimental cattle drawn from BEF free
areas and kept in insect proof isolation facilities
.there is no neutralising antibody present whe~
clinical signs commence. The minimum incu-
bation period of29 h reported by Mackerras et al
(1940) also argues against this aetiology. Clinical
recovery in experimental cases, where antibody
is not detected, and in natural cases where neu-
tralising antibody is rising rapidly while clinical
signs are still present (St. George et al 1984),
seems to occur in a similar time span. Thus
humoral antibody is not the key initiator of
recovery, though it probably consolidates
recovery and prevents virus recrudescence. A
schematic representation of the contrasting anti-
body responses is shown in Figure 3.
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Figzlre 1. This figure shows different febrile patterns in
experimental ephemeral fever. The febrile phases mav
sometimes be compressed or separated by short
periods of normal temperature when the cow may
appear to be quite well and with a normal appetite.
Figzlre 3. The neutralising antibody response of a cow
after clinical ephemeral fever without prior exposure
to Kimberley virus is compared schematically to those
which have experienced prior infection with this virus.
The inflammatory basis of the disease is
described in the preceding paper (Young and
Chung 1986) are in keeping. The neutrophilia
which overshadows a lymphocytopenia (Figures
4, 5) and a high plasma fibrinogen (St. George et
al 1984) are objective evidence of generalised
inflammation.
It is logical that if the disease has an inflamma-
tory basis, then anti-inflammatory drugs should
modify clinical signs. Anecdotal evidence of this
has been publIshed (St. George et al1984). More
recently, in 2 series of experiments, cattle were
method which had proven satisfactory for isolat-
ing various strains from natural cases into Aedes
albopictus cells (St. George 1985) was not suitable
for isolating the particular strain used to produce
experimental disease. A further development
of this method which relied on demonstrating
non-cytopathogenic BEF virus in Vero cells
subinoculated from Ae albopictus tissue cultures
(M F Uren, T D St. George and H Zakrzewski
unpub data) was reliable.
The viraemia was then related to fever in a
2-hourly observation cycle and a 4-hourly sam-
pling interval. This demonstrated that viraemia
commenced at least 4h before fever, but, a
further experiment, with a still more sensitive
method showed that the virus could be detected
in blood, albeit sporadically, during the incu-
bation period as well as during fever. In the series
of experimental cases, BEF virus was isolated
from leucocytes 23/78 times (30%) during incu-
bation, 123/139 (90%) during fever and 0/194
(0%) times in the convalescence phase. The
longest period over which virus was isolated
from a single animal was 8 days, including spor-
adic isolations during the incubation period of 5
days. The variation in the length of viraemia was
considerable, but was most reliably detected dur-
ing the fever.
In all these experimental cases of ephemeral
fever, there was a distinct gap of 48-96 h between
clinical recovery, with the accompanying cess-
ation of viraemia, and the first detection ofBEF
neutralising antibody in serum. This is in strong
contrast to many naturally infected cattle where
neutralising antibody rises rapidly before
recovery is complete. The accelerated rise has
been shown to be due to presensitisation of senti-
nel cattle by a previous infection with Kimberley
virus (St. George et al 1984; Cybinski 1986).
From such natural cases, it could be argued that
an antigen/antibody complex is a factor in the
initiation of ephemeral fever disease as antibody
capable ofneutralising BEF virus in vitro may be
present before and during disease. The dip in
neutralising antibodies in vivo on the first day of
illness suggests this occurs (St. George et aI1984).
Figllre 4. The relationship of interferon in the serum of
a cow is shown in relation to fever and illness in natu-
ral disease. The characteristic neutrophilia and
lymphocytopenia occur during disease.
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Figure 5. This cow was infected experimentally with
BEF virus. The relationship offever, interferon, leuco-
cytes, fibrinogen rise and the appearance of neutralis-
ing antibody is shown in relation to illness.
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Figzlre 6. Each of the cattle represented here was moni-
tored at 4 hourly intervals for leucocyte counts and the
presence of BEF virus in the blood. The early
phenylbutazone treated animal received phenylbuta-
zone from the day after infection, the late treated
animal after the onset of fever, and the one treated
with hydroxyurea from 6h prior to the onset of fever.
The fourth animal was not treated. A comparable per-
iod in the illness is considered. The bar represents
viraemia.
treated with phenylbutazone sodium, intra-
muscularly, at 8 mg/kilo, either from the day
after being inoculated intravenously with BEF
virus, or 8-hourly from 2 h after fever had defi-
nitely commenced. Controls were left untreated
(M F U ren, T D St. George, H Zakrzewski, unpub
data). In the first series of injections, treatment
was stopped after 2 days, apparently too early,
and fever, with clinical disease recurred. In the
second series, a total of 8-10 injections was
given. Early treatment suppressed clinical signs
completely (Table 2), and treatment at fever
caused remission. Immunity was not impaired as
judged by the appearance of neutralising anti-
body at a similar time after recovery (Table 2)
and resistance to challenge in contrast to con-
trols, with the same strain of BEF virus 2 weeks
after recovery. These experiments will be des-
cribed in detail in another publication.
Even under close observation, the cows which
were treated early were outwardly normal. The
contrast between treated and untreated cattle
was spectacular. However, treatment did not
abolish the neutrophilia (Table 3) (Fig. 6) though
its amplitude was reduced. The plasma fibrino-
gen levels rose only a minor amount above nor-
mal in the early treated cattle, and higher in the
cattle treated after the commencement of fever,
and in the untreated controls (Table 3).
A longer acting non-steroidal anti-inflam-
matory drug, flunixin megiumine (Finadyne
Schering Corp) in doses of 1.1,2.2,4.4 and 8.8
mgikilo each 24 h for 72 h suppressed signs and
fever for 8-10 h. However, increasing the dose
apparently did not extend the duration of effect,
even when it was given at levels which produced
toxic side-effects (T 0 St. George, unpub data).
Finadyne did not appear to offer any advantage
over the cheaper phenylbutazone.
We come to the commonest major compli-
cations of Figure 2. The neural signs of ephem-
eral fever are paralysis of hind or all limbs,
sternal recumbency with head turned to a flank,
lateral recumbency loss of reflexes (including the
swallowing reflex) followed by coma are similar
TABLE 2
Phenylbutazone Treatment
mild ocular discharge
TABLE 3
Phenylbutazone Treatment
(4 Cattle in Group)
Fibrinogen Peak above normal
(G/IOOml)NeutrophiliaDuration of Viraemia (h)Treatment
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to those in post-parturient hypocalcaemia. This
is a common condition observed in certain dairy
cows following the birth of their second or sub-
sequent calf and is treated successfully by veter-
inarians with intravenous infusions containing
calcium borogluconate. In 9 natural cases,
(St. George et af 1984) intravenous calcium
borogluconate elicited the same sequence of
response in ephemeral fever cases with neural
signs, as it does in post-parturient hypocal-
caemia. This direct response of neural signs to
chemical treatment rules out physical neural
damage. The milder cases maintained their
recovery, but the 2 most serious cases relapsed in
about 12 h after single treatment and died 1-2
days later. Other veterinarians in Australia (pers
comm) and South Africa (B. Erasmus pers
comm) have had similar success in ephemeral
fever cases which show clinical signs compatible
with hypocalcaemia. The paradox is that the
depression in total serum calcium levels is not
very severe (St. George et af 1984).
In cases of chronic paralysis after fever has
subsided, (Hill et al 1977) have shown that the
permanent paralysis, sometimes seen, is related
to Wallerian degeneration of the upper segments
of the cervical spinal cord. The mechanism by
which the temporary paralysis that is frequently
seen in the field disease becomes permanent par-
alysis, or whether there are 2 separate entities, is
unknown.
The role of neutrophils in the disease is uncer-
tain. Mackerras et al (1940), showed by the
inoculation of fractions of infected blood into
susceptible cows, that BEF virus was associated
with the leucocytes and not the erythrocytes. The
leucocyte component included the neutrophils.
Theodoridis (1969) detected BEF virus in 1euco-
cytes by immunofluorescence. Young (1979),
Young and Spradbrow (1985) have produced
ephemeral fever disease in susceptible cows by
the intravenous inoculation of infected
neutrophils contained in fluid collected from
serous cavities. Young and Chung (1986), in the
preceding paper, demonstrated convincingly
that masses of BEF virus are in the cytoplasm of
neutrophi1s in the tissues suffering an inflamma-
tory reaction in ephemeral fever. Young and
Spradbrow (1980) suppressed disease and the
development of immunity, but not viraemia, by
pretreatment of cattle with an anti-leucocyte
serum produced in a horse (Young and
Spradbrow 1984).
In contrast, an effective dampening of
neutrophilia by the intravenous infusion of
hydroxyurea into 6 cows did not prevent clinical
signs, nor the subsequent development of
immunity as judged by the appearance of neu-
tralising antibodies (Table 2) and resistance to
challenge (M F Uren, T D St. George, H
Zakrzewski unpub data). However, our chemical
treatment of cattle with phenylbutazone elimin-
ated clinical signs, but not the neutrophilia and
later resistance. This apparent paradox between
the effects of anti1eucocyte and chemical treat-
ments has yet to be resolved.
BEF InfectionInterferon To.x-icity In Man
Fever
Heart Rate
Malaise
Headache
Aching Joints Lameness!
Stiffness
Transient
Lymphopenia
Neutrophilia
Lymphopenia
Neutrophilia
Young (1979) showed that interferon was pre-
sent in ephemeral fever, but did not relate it well
to signs. We have shown that high levels (peaks
up to 2-3000) of serum interferon occur prior to
commencement of fever in cattle experimentally
infected with BEF virus (Fig. 5). In experimental
cases, the interferon levels rose before the onset
of fever and fell before a corresponding decline
of fever. Thus recovery occurs from ephemeral
fever after the serum interferon level falls, not as
it rises. This demonstrates that an effect which is
consistent with the known toxic effects of high
doses of synthetic interferon follows the appear-
ance of high levels of natural interferon(s) in the
serum. In sentinel cattle interferon was also pre-
sent in the serum collected during early fever,
before obvious clinical signs appeared (Fig. 4).
Interferon was not detected in serum samples
taken daily up to a week before and after the
period of illness in these cattle.
The development of high titres of interferon
and the pattern of decline is not affected by
phenylbutazone treatment. The results of treat-
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The association between neutrophils andBEF
virus presents 2 possibilities. The first is that the
neutrophils engulfBEF virus, which has multi-
plied in the inflamed tissues, along with tissue
debris, or else the neutrophils arrive at the affec-
ted tissues in response to a stimulus arising from
damage to tissue by another factor, but are
already carrying BEF virus in their cytoplasm.
Treatments appear to affect viraemia in various
ways (Fig. 6).
In order to have a toxaemia as proposed in our
hypothesis there must be a toxin. Interferon has
been demonstrated to produce toxic effects in
human volunteers (Table 4), many similar to
those of ephemeral fever in cattle and these
effects are preventable by pretreatment with
indomethacin (Scott et al 1981). Their pre-
treatment did not prevent the neutrophilia~
lymphocytopenia and fall in plasma zinc or
affect the plasma interferon levels in spite of pre-
venting or relieving signs and symptoms pro-
duced by interferon in controls. Headache can-
not be confirmed in cattle but their appearance
certainly suggests that they could be suffering a
very severe headache.
TABLE 4
A comparison of the toxic effects of synthetic inter-
feron on healthy human volunteers (Scott et al
1981) with the signs observed in cattle with
ephemeral fever.
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ment with phenylbutazone in cows parallels that
treatment of human patients with indomethacin
(Scott et a11981, 1983). The treatment must pre-
vent some event between interferon and the
responding tissue, but certain other events are
unaltered.
In summary, the clinical signs of ephemeral
fever are preventable, or reversible, by chemical
treatment, although BEF virus is present in the
bloodstream during treatment (Fig. 6). Further
evidence of the biochemical events which occur
in ephemeral fever, will be presented in the paper
which follows (Murphy et a11986) and may pro-
vide answers to questions arising from some of
the statements in this paper.
While the underlying mechanisms of ephem-
eral fever remain obscure, it appears that the
virus induces its effects indirectly, rather than by
causing direct massive cell destruction, cell mul-
tiplication or by antigen/antibody complexing.
At least some of the effects ofBEF virus may be
prevented by interrupting a cascade ofbiochemi-
cal events, perhaps those induced by toxic levels
of interferon. The interferons produced in
response to the infection by BEF virus, as well as
having the beneficial effect of limiting virus mul-
tiplication and bringing the disease to resolution,
may actually initiate the disease process which
we know as bovine ephemeral fever.
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